"Thymine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of four constituent bases of DNA.
| Descriptor ID |
D013941
|
| MeSH Number(s) |
D03.383.742.698.875.899
|
| Concept/Terms |
Thymine- Thymine
- 5-Methyluracil
- 5 Methyluracil
|
Below are MeSH descriptors whose meaning is more general than "Thymine".
Below are MeSH descriptors whose meaning is more specific than "Thymine".
This graph shows the total number of publications written about "Thymine" by people in this website by year, and whether "Thymine" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 4 | 4 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 4 | 6 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 5 | 6 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 4 | 5 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 3 | 3 |
| 2020 | 1 | 2 | 3 |
| 2021 | 3 | 2 | 5 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 1 | 2 |
| 2024 | 1 | 1 | 2 |
Below are the most recent publications written about "Thymine" by people in Profiles.
-
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis. Eur J Cancer. 2024 Aug; 207:114160.
-
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients. Int J Cancer. 2024 May 15; 154(10):1794-1801.
-
Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives. Peptides. 2024 Feb; 172:171147.
-
A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma. Clin Colorectal Cancer. 2024 03; 23(1):67-72.
-
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen. Med Oncol. 2022 May 23; 39(5):102.
-
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer. Curr Probl Cancer. 2022 04; 46(2):100793.
-
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment. Cancer Chemother Pharmacol. 2021 09; 88(3):485-497.
-
RNA Editing of the Human DNA Glycosylase NEIL1 Alters Its Removal of 5-Hydroxyuracil Lesions in DNA. Biochemistry. 2021 05 18; 60(19):1485-1497.
-
Glucocorticoid receptor modulators decrease alcohol self-administration in male rats. Neuropharmacology. 2021 05 01; 188:108510.
-
Thymine dissociation and dimer formation: A Raman and synchronous fluorescence spectroscopic study. Proc Natl Acad Sci U S A. 2021 02 09; 118(6).